Summary A method is described enabling the direct measurement of vincristine resistance in intact tissues in vivo by morphological study. Using the metaphase arresting properties of the drug, counts were made of escaping anaphase and telophase mitotic figures at a range of doses. The proportion of post-metaphase mitotic figures is called the post-metaphase index (PMI). In 95 primary intestinal tumours induced by dimethylhydrazine (DMH) in rats, an increase in resistance to vincristine was shown over normal mucosa (P<0.001).The data were analysed by computer modelling and a linear relationship is demonstrated between the logit of the post-metaphase index, and log dose of vincristine. To achieve a PMI of 1% the fitted lines show an enhanced vincristine dose requirement over normal mucosa of 6 times in colonic tumours, and 8 times in small intestinal tumours. Non-neoplastic mucosa from the DMH-treated animals requires an enhanced dose of vincristine of 1.5 times, compared with normal mucosa, to achieve a PMI of 1%.Given current interest in the mechanism of vincristine resistance in cell lines this new approach provides a technique for assessing the resistance of solid tumours, both in vivo and in vitro, and for subsequent experimental manipulation.Certain drugs, including the Vinca alkaloids and colcemid, have the ability to arrest dividing cells during the mitotic process, by inhibition of microtubular polymerisation in the formation of the mitotic spindle. The resulting 'arrested metaphase' mitotic figures are readily recognisable and provide one approach to the determination of indices of cell proliferation by morphological means, the so-called stathmokinetic experiment. In conventional cellkinetic studies a large dose of the stathmokinetic agent is used in order to arrest all cells entering mitosis, and at full arrest no mitotic figures appear as anaphases or telophases. The rate of accumulation of the dividing cells then gives the cell birth rate (Tannock, 1967;Steel, 1977).In a recent stathmokinetic study of human colorectal carcinoma grown in organ culture Pritchett et al. (1982) showed that tumours required a sixfold larger dose of vincristine to achieve full metaphase arrest than did non-neoplastic mucosa from the same resection specimen. This in vitro observation mirrors the disappointing clinical experience of vincristine treatment of bowel cancer. Much current interest relates to the biochemical, pharmacological and genetic basis of the observed resistance of cancer cells to chemotherapeutic agents. In the case of resistance to the Vinca alkaloids there is an association with the pleiotropic multidrug resistance phenotype (Ling et al., 1983) involving the cell surface glycoprotein P180 (Garman et al., 1983). In several studies using cell lines of both rodent and human origin, in which Correspondence: P. Ince.